WeightWatchers is now only offering Wegovy while other telehealth providers defiantly hang on to compounded alternatives.

Cornell University researchers have developed an implant system that can treat Type 1 diabetes by supplying extra oxygen to densely packed insulin-secreting cells, without the need for ...

A user further opined that the range of $400-$450 is a good entry point for the stock.